Skip to main content

Day: February 9, 2026

Transocean to Acquire Valaris

Creates the world’s highest-quality, highest-specification offshore drilling fleet Companies to host conference call today at 8 a.m. CT / 9 a.m. ET STEINHAUSEN, Switzerland and HAMILTON, Bermuda, Feb. 09, 2026 (GLOBE NEWSWIRE) — Transocean Ltd. (NYSE: RIG) and Valaris Limited (NYSE: VAL) today announced the signing of a definitive agreement to combine the two companies under which Transocean will acquire Valaris in an all-stock transaction valued at approximately $5.8 billion (all currency in USD). The shareholding percentages of the combined company, on a fully diluted basis1, will be approximately 53% for Transocean and 47% for Valaris. The enterprise value of the pro forma company is approximately $17 billion. HighlightsCreates an industry leader with a diversified offshore fleet of 73 rigs, including 33 ultra-deepwater drillships,...

Continue reading

Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease

TORONTO, Feb. 09, 2026 (GLOBE NEWSWIRE) — Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced that a scientific team led by Dr. Justin Chun at the University of Calgary has published new data in the peer-reviewed journal Inflammation Research identifying interleukin-32 (IL-32) as a novel lipid droplet-associated cytokine that may contribute to tubular injury and inflammation in diabetic kidney disease (DKD). The newly published findings, based on human kidney tissue, show that during DKD, kidney cells accumulate lipid (fat) droplets that are coated with the cytokine IL-32. The build-up of IL-32 on lipid droplets in cells is believed to drive kidney injury and inflammation. These data identify IL-32 as a potential link between metabolic dysregulation and inflammation, pathways that...

Continue reading

Prospect Enhanced Yield Fund, a Debt-Focused Structured Credit Interval Fund, Announces 10.6% Net Annualized 3-Month Total Return and 9.0% Cash Dividend Yield (on Net Asset Value) on Fully Deployed Anchor Capital

NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) — Prospect Enhanced Yield Fund (the “Fund”, CUSIP “PAYIX”), a debt-focused structured credit interval fund with daily net asset value and quarterly mandatory liquidity, has announced recent performance results. For the three month period ended January 31, 2026, since fully deploying the Fund’s anchor capital, the Fund has delivered an annualized total gross return of 10.6% (total net return of 10.6%i) based on net asset value, reflecting strong performance on an absolute basis and relative to a range of comparable exchange-traded funds (“ETFs”) and relevant market indices over the same period. During the same period, the Fund produced 147bps and 434bps higher annualized returns than two leading ETFs with comparable targeted asset classes and investment objectives. During the same period,...

Continue reading

Jeffs’ Brands: KeepZone AI Enters Into Anti-Submarine and Underwater Security Systems with Strategic Agreement

Exclusive agreement with a global leader in underwater domain awareness to support Mexican maritime and offshore security operations Tel Aviv, Israel, Feb. 09, 2026 (GLOBE NEWSWIRE) — Jeffs’ Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace expanding into the global homeland security sector through advanced artificial intelligence (“AI”) -driven solutions, recently announced that its wholly-owned subsidiary, KeepZone AI Inc. (“KeepZone”), has entered into an exclusive reseller agreement (the “Agreement”) with a global leader in underwater domain awareness and acoustic intelligence solutions.  KeepZone will help lead the counterparty’s entry into the Mexican market to counter underwater drug smuggling and protect offshore assets,...

Continue reading

WISDOMTREE NATURAL GAS 3x DAILY LEVERAGED SECURITIES NOTICE OF ADJOURNMENT OF MEETING

9 February 2026 LEI: 2138003QW2ZAYZODBU23 LSE Code: 3NGL WISDOMTREE MULTI ASSET ISSUER PUBLIC LIMITED COMPANY(a public company incorporated with limited liability in Ireland)WISDOMTREE NATURAL GAS 3x DAILY LEVERAGED SECURITIESISIN: XS2819843900 PROPOSED AMENDMENT TO THE PRINCIPAL AMOUNT OF THE AFFECTED SECURITIES ADJOURNMENT OF MEETING OF THE ETP SECURITYHOLDERS THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt about what action you should take, you are recommended to consult your independent financial adviser. If you have sold or transferred all of your WisdomTree Natural Gas 3x Daily Leveraged Securities (the “Affected Securities”) of WisdomTree Multi Asset Issuer Public Limited Company (the “Issuer”), please send this document, together with the accompanying form of proxy, at once to the purchaser...

Continue reading

Swvl Secures a New Up to $1.5 Million Multi-Year Contract in Saudi Arabia, Expanding Its Healthcare Mobility Footprint Across the GCC

DUBAI, United Arab Emirates, Feb. 09, 2026 (GLOBE NEWSWIRE) — Swvl Holdings Corp (“Swvl” or the “Company”) (Nasdaq: SWVL), a leading provider of technology-enabled mass mobility solutions, today announced the signing of a new three-year contract valued at up to $1.5 million in the Kingdom of Saudi Arabia (“KSA”), marking a significant expansion of its healthcare mobility operations across the Gulf Cooperation Council (“GCC”). The agreement will support patient, medical staff, and equipment transportation across healthcare facilities, leveraging Swvl’s technology platform to enable dynamic route planning, real-time dispatching, and operational optimization. The deployment is designed to support on-demand and time-critical mobility requirements while maintaining high standards of safety, service quality, and operational visibility. The...

Continue reading

Sportradar to Power NBA Fan Experiences Across NBC Sports Regional Sports Networks through Advanced Data and Enhanced Visual Storytelling

ST GALLEN, Switzerland and NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) — Sportradar AG (NASDAQ: SRAD) today announced a multi-year agreement with NBC Sports Regional Sports Networks (RSNs) to enhance the NBA viewing experience through real-time, cutting-edge broadcast solutions that enhance live game coverage. NBC Sports Regional Networks will leverage Sportradar’s NBA Advanced Data and GameFrame across live NBA game broadcasts during the 2025-26 and 2026-27 NBA seasons. The agreement supports hundreds of NBA telecasts across NBC Sports’s regional networks, delivering more dynamic coverage to fans in multiple NBA markets nationwide. At the center of the partnership is GameFrame, which uses AI to transform live NBA player-tracking data into on-air graphics, animated replays, shot charts, and customized digital assets. GameFrame supports...

Continue reading

Inotiv Reports First Quarter Financial Results for Fiscal 2026 and Provides Business Update

–   First quarter fiscal 2026 revenue increased 0.8% compared to prior year quarter to $120.9 million –   First quarter fiscal 2026 operating loss increased 5.3% compared to prior year quarter to $16.3 million –   Conference call scheduled for today at 8:30 am ET WEST LAFAYETTE, Ind., Feb. 09, 2026 (GLOBE NEWSWIRE) — Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced financial results for the three months (“Q1 FY 2026”) ended December 31, 2025. Revenue by Segment (in millions of USD)  Three Months EndedDecember 31,   %change(1)    2025   2024        (unaudited)   (unaudited)      DSA (Discovery & Safety Assessment) $ 48.0   $ 42.8   12.0  %  RMS...

Continue reading

Novo Nordisk takes legal action against Hims & Hers to protect patients from unsafe, knock-off Wegovy® and Ozempic®

Hims & Hers unlawfully mass markets unapproved versions of Novo Nordisk’s FDA-approved semaglutide medicines, deceiving patients and putting their health at risk Novo Nordisk takes decisive legal action to stop Hims’ illegal conduct, protect public health, and defend the scientific innovations that deliver better health outcomes to Americans living with serious chronic diseases like obesity and diabetes Novo Nordisk is asking the court to permanently ban Hims from selling unapproved, compounded drugs that infringe our patents, and is seeking to recover damagesPlainsboro, NJ, US and Bagsværd, Denmark, February 9, 2026 – Novo Nordisk announced today that it has filed a lawsuit against telehealth company Hims & Hers (“Hims”), for infringing US Patent 8,129,343 with Hims’ compounded semaglutide products for the US market. Hims...

Continue reading

Descartes Showcases AI Innovations to Help Improve Supply Chain and Logistics Operations

ATLANTA, Feb. 09, 2026 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, is showcasing its latest technology innovations focused on artificial intelligence (AI) and advanced automation at Manifest 2026 from February 9–11 in Las Vegas. Descartes’ solutions leverage its Global Logistics Network to help organizations of all sizes operate more intelligently, securely and resiliently in complex supply chain and logistics environments where execution, compliance, and risk mitigation matter. “AI and data-driven automation are becoming essential to managing modern businesses and logistics leaders are under pressure to operate smarter, safer and faster across increasingly intricate supply chains,” said Ken Wood, Executive Vice President, Product Management...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.